Gilead issues USD 3 billion in senior notes under new supplemental indenture
Gilead Sciences
Gilead Sciences GILD | 0.00 |
- Gilead entered an Eleventh Supplemental Indenture with Computershare Trust Company, National Association as trustee to issue USD 3 billion of senior notes in a public offering.
- Financing includes USD 500 million of 4.25% Senior Notes due 2028, USD 1 billion of 4.4% Senior Notes due 2029, USD 1 billion of 4.6% Senior Notes due 2031, USD 500 million of 4.9% Senior Notes due 2034.
- Net proceeds earmarked for general corporate purposes, including potential acquisitions, investments, strategic transactions, or other business opportunities.
- Indenture terms include limits on secured debt, sale-leaseback transactions, certain mergers or asset transfers, plus a change-of-control repurchase offer requirement.
- Notes are redeemable in whole or in part at applicable redemption prices.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-064518), on May 20, 2026, and is solely responsible for the information contained therein.
